Joyce El Hokayem
From a better understanding of cancer genomes, clinicians can select the most suitable treatments available for a cancer patient.
Human Genetics Scientist, Joyce El Hokayem, continues her discussion on innovations within cancer treatment.
Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012. The number of new cases is expected to rise by about 70% over the next 2 decades.
The genome-editing system based on CRISPR-Cas is becoming a valuable tool for different applications in biomedical research, drug discovery and human gene therapy by gene repair and gene disruption, gene disruption of viral sequences, and programmable RNA targeting.